Empresaria Share Discussion Threads

[sharesoc] 30/5/2019 13:14

A quick reminder that Empresaria present at our next London growth company seminar on the 12th June, which may be of interest to current shareholders and potential investors. More details can be found here:

[harrogate] 22/5/2019 11:24

Surely some mistake putting EMR and growth in same sentence!?

[sharesoc] 22/5/2019 11:13

Empresaria present at our next London growth company seminar on the 12th June, which may be of interest to current shareholders and potential investors. More details can be found here:

[merrimac] 07/5/2019 09:19

The chair of recruitment firm Empresaria Group PLC said Tuesday the company was on course to meet full year forecasts after first quarter net fee income grew on the year prior.

In his annual general meeting statement, Chair Tony Martin explained that it had "delivered year on year growth in net fee income for the first quarter of 2019."

Consequently, it was "on course to meet market expectations for the full year, with the group's profit contribution anticipated to be more second half weighted due to the previously highlighted increase in central staff costs, new office openings and our brands in Germany and Japan starting this year from a lower base position."

In 2018, Empresaria generated GBP9.4 million in pretax profit on revenue of GBP366.8 million. Net fee income stood at GBP72.3 million.

Martin added that its investment in Grupo Solimano in Peru was "performing well and in line with our expectations." In July 2018, Empresaria acquired a 60% stake in staffing services firm Solimano for up to GBP2.1 million.

Shares in Empresaria were 0.7% lower at 73.51 pence on Tuesday. The firm will release its interim results on August 21.

By Ahren Lester; [e-mail]

[graham1ty] 07/5/2019 06:16

Ok statement and inline. But the dreaded second half weighting rears it’s head......always ominous.

With the acquisitions, it would have been disappointing if net fee income had NOT been up. And they are flagging much higher costs. No sign of a pick up in underlying trading. No mention of the problem markets ( Germany and Japan) and whether they are on the road to recovery.

A bit disappointing

[graham1ty] 07/5/2019 06:00

EMR AGM today. Anyone going ? I am going to be pushed to get there

[tomps2] 13/3/2019 07:43

EMR FY results overview by Spencer Wreford, CEO and Tim Anderson, Group Finance Director.

Spencer Wreford, CEO and Tim Anderson, Group FD talk through the FY18 results, their strategy and the outlook. Debt down. Dividend up 50%.

[merrimac] 13/3/2019 07:27

Generally a good diversified company...not sure I like the number of shares that are illiquid but I do like their approach. This dividend payout looks highly favourable too and puts more of the profits back to the investor (as they should with the capital arrangements they now have).

[graham1ty] 13/3/2019 07:17

Pretty good results. No banana skins.

Debt down ( a bit) and almost all metrics steady, or up a bit.

I think the market has been factoring in a disaster and EMR have NOT produced any negative surprises. That makes a p/e of 5 possibly a little low !

[opodio] 19/11/2018 07:36

Change of Auditor



Always a very dodgy signal

[graham1ty] 22/10/2018 07:03

New COO appointed. She says : “ I believe there is significant opportunity for Empresaria to play a much bigger role in the industry and I am excited to work closely with the Board and with the Empresaria brands to drive organic growth and to continue to strengthen our position”

Yes, I wish EMR had a bigger role....well, actually a higher share price !

[merrimac] 29/8/2018 13:19

So they haven't changed their view from July where they said 100p. This current 100p is dependent on forecasts into 2019. Interestingly, they had said a PER of 11.7 earlier last year but I think at that time there were no market cautions. I think they are a fairly strong quality company and that the price will come back nicely once they start to show improvements in debt and cashflow.

[graham1ty] 29/8/2018 12:38

Is new research on the Emr website. Click through Analysts, leads you to a link to Allenby research. No changes to forecast 12.6p fully diluted and target price 100p.

A long way from 150p+ last year......

[merrimac] 23/8/2018 09:10

Did you see their update? Doesn't seem revised just market updated...there were no surprises.....seems like the negative view is departing but still not many shares available.....

[graham1ty] 23/8/2018 08:04

Are there any revised forecasts ?

[tomps2] 22/8/2018 06:33

Empresaria Group (EMR) H1 results August 2018 - video



Empresaria Group CEO Spencer Wreford and Group Finance Director Tim Anderson present highlights of the Group’s interim results for the 6 months ended 30th June 2018.
Spencer Wreford (CEO) Overview – 00:21
Tim Anderson (Group FD) Financial highlights – 05:35
Spencer Wreford (CEO) Outlook – 07:39

[merrimac] 22/8/2018 06:29

To add...it is worth watching the link to the CEO interview...tbh, that is where I formed my opinion.

[merrimac] 22/8/2018 06:20

Boring, solid, and honest. Like the way they have presented the results.

[merrimac] 10/8/2018 05:27

So if HVN have been offered 9.1x EV/EBITDA per share, this would indicate that EMR's are price is exceptionally undervalued - reported EV/EBITDA is around 4.2x, my calculation gives less than that.

[merrimac] 09/8/2018 10:03

What is the HVN effect? Updated, yes of course, Harvey Nash! Duh..

[davebowler] 09/8/2018 09:47

HVN effect?

[daneswooddynamo] 25/7/2018 14:51

Maybe liontrust fully exited ?